NSE filing, NSE: RAINBOW. Summary written from the filing by ALFA Finder's alert engine.
Rainbow Childrens Medicare Ltd: key numbers
- Share price
- ₹1,262.00
- Market cap
- ₹12,818 Cr
- Revenue (annual)
- ₹1,703 Cr
- Net profit (annual)
- ₹278.3 Cr
- P/E (TTM)
- 43.9×Sector 53.4×
- Promoter holding
- 49.83%-0.01% QoQ
- FII holding
- 14.66%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rainbow Childrens Medicare Ltd
All →Rainbow Childrens Medicare Earnings Call Transcript: Key Takeaways
Rainbow delivered robust 23.2% revenue growth despite a soft monsoon impacting seasonal pediatric volumes.
- Call
- Guides 18% growth
Rainbow Childrens Medicare Results Update
Rainbow Children's Medicare reported Q2 FY27 revenue of Rs. 5,480 Mn, up 23% YoY, with PAT of Rs. 839 Mn. Nellore and Guntur hospitals commenced operations during the quarter.
- hospital beds
- 120.0 beds
Rainbow Childrens Medicare Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹548 Cr (+23% YoY) and PAT ₹84 Cr (+11%). Post-IndAS EBITDA margin fell to 31.0% from 33.5%. Strategy is hub-and-spoke pediatric and maternity expansion across 26 hospitals.
Rainbow Childrens Medicare Q2 FY27 Results: Net Profit ₹83.9 Cr, Up 11.0% YoY
Rainbow Childrens Medicare Ltd reported revenue from operations of ₹548 Cr (+23.2% YoY) and net profit of ₹83.9 Cr (+11.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹83.9 Cr · +11.0% YoY
Rainbow Childrens Medicare Board Meeting Date
Rainbow Children's Medicare will hold a board meeting on 31-Oct-2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The trading window stays closed until 48 hours after the results.
Rainbow Childrens Medicare Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.
Other merger & restructuring announcements
All →Oval Projects Engineering Merger & Restructuring Worth ₹0.03 Cr
Oval Projects will form a 50:50 joint venture, Oval Eiko Resources, with Eiko Scientific Solutions LLP for biogas. Cash consideration is Rs.0.03 Crore; incorporation is pending.
- Value
- ₹0.03 Cr
Oval Projects Engineering Merger & Restructuring
Oval Projects Engineering will form a 50:50 joint venture with Eiko Scientific Solutions LLP for renewable energy. The board also deferred a warrant fundraise to a later meeting.
SecMark Consultancy Merger & Restructuring Worth ₹0.01 Cr
SecMark Consultancy's board approved incorporating wholly owned subsidiary SecMark Mineral Exchange Private Limited. The company will subscribe Rs 1 lakh for its initial share capital.
- Value
- ₹0.01 Cr
Powerica Merger & Restructuring Worth ₹2.12 Cr
Powerica plans to sell a 49% stake in Windstride Power to GE Renewable for ₹2.12 Crore cash. Completion is expected within six months, by May 2027.
- Value
- ₹2.12 Cr
Eiko Lifesciences Merger & Restructuring
Eiko Lifesciences' wholly owned subsidiary Eiko Scientific Solutions LLP will form a 50:50 joint venture, Oval Eiko Resources, with Oval Projects Engineering. The JV targets compressed bio gas production and distribution.
Welspun Enterprises Merger & Restructuring Worth ₹339.4 Cr
Welspun Enterprises completed the final tranche sale of its 51% stake in associate NXT Infra MCP to NXT-Infra Trust for about ₹339.38 Crore. NXT Infra MCP ceases to be an associate of the company.
- Value
- ₹339.4 Cr